Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
21.5M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$578M
-
Value change
-
+$37.8M
-
Put/Call ratio
-
0.43
-
Number of buys
-
51
-
Number of sells
-
-62
-
Price
-
$26.96
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q1 2022
154 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.5M shares
of 27.2M outstanding shares and own 78.97% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (3.76M shares), STATE STREET CORP (3.22M shares), ARK Investment Management LLC (2.38M shares), BlackRock Inc. (1.7M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.4M shares), Nikko Asset Management Americas, Inc. (1.4M shares), VANGUARD GROUP INC (1.15M shares), FMR LLC (921K shares), Point72 Asset Management, L.P. (425K shares), and GEODE CAPITAL MANAGEMENT, LLC (371K shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.